Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide Intrapolyp Injection in Type 2 CRSwNP
NCT05931744Phase 3Completed
- Sponsor
- Kafrelsheikh University
- Start
- May 2021
- Primary completion
- Feb 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of EPI-EE in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by Kafrelsheikh University. Started May 2021; status: completed.
02
Drugs
EPI-EE
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT05931744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05931744.